45 results on '"Lorant, Tomas"'
Search Results
2. #1985 Tocilizumab in chronic active antibody-mediated rejection: a randomized controlled open-label multi-center trial (INTERCEPT study)
3. Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
4. Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients
5. IgM single antigen bead HLA-assay is affected by imlifidase through the cleavage of IgG but not IgM
6. Challenges in the Management of Kidney Allograft Herniation With a Single-stage Pedicled Anterolateral Thigh Flap
7. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
8. Imlifidase desensitization in crossmatch-positive, highly-sensitized kidney transplant recipients: Results of an international phase 2 trial (Highdes)
9. Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
10. Perfusion of Porcine Kidneys With Macromolecular Heparin Reduces Early Ischemia Reperfusion Injury
11. Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
12. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
13. Imlifidase-generated Single-cleaved IgG: Implications for Transplantation
14. Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
15. Imlifidase-generated Single-cleaved IgG: Implications for Transplantation
16. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation
17. EFFECT OF STATINS ON RECURRENCE OF IgA NEPHROPATHY AND GRAFT LOSS: RO-211
18. Graft morphology correlates with fibroblast activity in cardiac allograft rejection
19. Liver regeneration is impaired by FK778 in partially hepatectomized rats, while supplemental uridine restores both liver growth and hepatocyte proliferation
20. The graft content of hyaluronan is increased during xenograft rejection
21. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts
22. Isolation of mouse-to-rat cardiac xenograft-infiltrating cells by ex vivo propagation
23. Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse
24. High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer
25. Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation – experiences from a prospective, clinical, observational study
26. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti‐HLAantibodies by IdeS (imlifidase) in chronic kidney disease patients
27. Modifying the vessel walls in porcine kidneys during machine perfusion
28. Refined Microdialysis Method for Protein Biomarker Sampling in Acute Brain Injury in the Neurointensive Care Setting
29. Utilization of Small Pediatric Donors Including Infants for Pancreas and Kidney Transplantation
30. Studies of Rejection in Experimental Xenotransplantation
31. Oxygen-charged HTK-F6H8 emulsion reduces ischemia–reperfusion injury in kidneys from brain-dead pigs
32. Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation
33. Screening of mortality in transplant patients using an assay for immune function
34. Sinus Excision and Primary Closure Versus Laying Open in Pilonidal Disease: A Prospective Randomized Trial
35. Liver regeneration is impaired by FK778 in partially hepatectomized rats, while supplemental uridine restores both liver growth and hepatocyte proliferation
36. T Lymphocyte Trafficking: A Novel Target for Neuroprotection in Traumatic Brain Injury
37. T-cell inhibition does not aggravate bacterial translocation from rat small bowel
38. Phenotyping of ex vivo propagated graft-infiltrating cells—A tool to monitor rejection in the early post-operative period
39. Regulation of Fibroblasts by Activated and Non-activated Immune Cells
40. ORAL ADMINISTRATION OF XENOGENEIC ERYTHROCYTES INDUCES PRODUCTION OF ANTIBODIES THAT ARE CAPABLE OF INDUCING HYPERACUTE REJECTION OF CONCORDANT VASCULARIZED XENOGRAFTS
41. Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.
42. Standardized experimental brain death model for studies of intracranial dynamics, organ preservation, and organ transplantation in the pig.
43. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
44. Intestinal mucosal perfusion and integrity are maintained in hypotensive brain dead mice.
45. [Kidney transplanted persons with malignant tumors is a growing patient group].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.